BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou R, Yan L, Dong X, Zhu S, Chen K, Wu Y, Xiang H, Li L, Zhang G, Gu Z, Zhao Y. Fractionated regimen-suitable immunoradiotherapy sensitizer based on ultrasmall Fe4Se2W18 nanoclusters enable tumor-specific radiosensitization augment and antitumor immunity boost. Nano Today 2021;36:101003. [DOI: 10.1016/j.nantod.2020.101003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo Z, Xin Y, Yang L, Ran R, Wan G, Ma A, Ren H, Wang Y, Yang X. Biomimetic nanotherapeutics based on oxygen supply and ultrasmall Cu-Se-Au alloy nanoparticles for boosting radio-photothermal ablation of breast cancer. Nano Today 2022;46:101587. [DOI: 10.1016/j.nantod.2022.101587] [Reference Citation Analysis]
2 Tang Z, Wang M, Jia X, Xie S, Chen P, Wang D, Chen L, Zhao J. Organophosphonic Acid-Regulating Assembly of PV-SbIII Polyoxotungstate and Its Potential in Building a Dual-Signal Readout Electrochemical Aptasensor for Carcinogen Detection. Inorg Chem 2022. [PMID: 36073797 DOI: 10.1021/acs.inorgchem.2c02003] [Reference Citation Analysis]
3 Shang Y, Chen Y, Wang Q, He Y, He S, Yu S, Liu X, Wang F. Construction of an endogenously activated catalytic DNA circuit for highly robust in vivo microRNA imaging. Nano Today 2022;45:101553. [DOI: 10.1016/j.nantod.2022.101553] [Reference Citation Analysis]
4 Ji C, Zhao M, Wang C, Liu R, Zhu S, Dong X, Su C, Gu Z. Biocompatible Tantalum Nanoparticles as Radiosensitizers for Enhancing Therapy Efficacy in Primary Tumor and Metastatic Sentinel Lymph Nodes. ACS Nano 2022. [PMID: 35666259 DOI: 10.1021/acsnano.2c02314] [Reference Citation Analysis]
5 Yang W, Zhang M, Zhang J, Liu Y, Ning J, Yang J, Zhang Z, Hou L, Chen X. In vivo activated T cell targeting with PD-1/PD-L1 blockade for sequential treatment mediated cancer immunotherapy. Nano Today 2022;44:101492. [DOI: 10.1016/j.nantod.2022.101492] [Reference Citation Analysis]
6 Wang Y, Zhang H, Liu Y, Younis MH, Cai W, Bu W. Catalytic radiosensitization: Insights from materials physicochemistry. Materials Today 2022. [DOI: 10.1016/j.mattod.2022.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen J, Dong H, Bai L, Li L, Chen S, Tian X, Pan Y. Multifunctional high-Z nanoradiosensitizers for multimodal synergistic cancer therapy. J Mater Chem B 2022;10:1328-42. [PMID: 35018941 DOI: 10.1039/d1tb02524d] [Reference Citation Analysis]
8 Cao Z, Yang W, Min X, Liu J, Cao X. Recent advances in synthesis and anti-tumor effect of organism-modified polyoxometalates inorganic organic hybrids. Inorganic Chemistry Communications 2021;134:108904. [DOI: 10.1016/j.inoche.2021.108904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Feng Y, Wu J, Chen J, Lin L, Zhang S, Yang Z, Sun P, Li Y, Tian H, Chen X. Targeting dual gene delivery nanoparticles overcomes immune checkpoint blockade induced adaptive resistance and regulates tumor microenvironment for improved tumor immunotherapy. Nano Today 2021;38:101194. [DOI: 10.1016/j.nantod.2021.101194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chen K, Wang Y, Liang H, Huang H, Liang Y, Zhang J, Chang Y, Li J, Fang M, Xing G. Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure. Nano Today 2021;37:101070. [DOI: 10.1016/j.nantod.2020.101070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lu F, Wang M, Li N, Tang B. Polyoxometalate-Based Nanomaterials Toward Efficient Cancer Diagnosis and Therapy. Chemistry 2021;27:6422-34. [PMID: 33314442 DOI: 10.1002/chem.202004500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]